SCHEMBL15517522

SCHEMBL15517522

CCN(CCO)C1=CC(=O)C=CC1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC29A1 Q99808 1/20 0.35
▸ HTT P42858 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ MITF O75030 1/20 0.34
▸ NSD2 O96028 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ GALK1 P51570 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ACHE P22303 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ GAA P10253 1/20 0.31
▸ ERBB2 P04626 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3341534 0.89 MAPT (0.37) HTTMAPTNPC1MITFNSD2
SCHEMBL28562469 0.85 ACHE (0.38) MAPTALDH1A1RECQLBLMACHE
SCHEMBL8756842 0.78 ALDH1A1 (0.35) MAPTALDH1A1RECQLL3MBTL1ACHE
SCHEMBL28549550 0.77 ACHE (0.40) MAPTALDH1A1RECQLACHEBACE1
SCHEMBL28570427 0.74 ACHE (0.46) MAPTALDH1A1RECQLACHEBACE1
SCHEMBL28553031 0.71 ACHE (0.51) MAPTALDH1A1ACHEBACE1
SCHEMBL3673241 0.69 MEN1 (0.38) MAPTALDH1A1RECQLERBB2
SCHEMBL21814508 0.67 ALDH1A1 (0.34) HTTMAPTALDH1A1RECQLRAB9A
SCHEMBL15020301 0.67 DNM1 (0.56) HTTMAPTNPC1MITFNSD2
SCHEMBL28247119 0.66 ACHE (0.44) MAPTALDH1A1RECQLACHEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796730-B2 Halogenated benzoxazines and their use EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) 2017-10-24 — — US disclosed
US-9796730-B2 Halogenated benzoxazines and their use EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) 2017-10-24 — — US disclosed
EP-2890700-A1 HALOGENATED BENZOXAZINES AND USE THEREOF Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) 2015-07-08 — — EP disclosed
US-20150166572-A1 HALOGENATED BENZOXAZINES AND THEIR USE EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) 2015-06-18 — — US disclosed
US-20150166572-A1 HALOGENATED BENZOXAZINES AND THEIR USE EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) 2015-06-18 — — US disclosed
WO-2014032732-A1 HALOGENATED BENZOXAZINES AND USE THEREOF EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT (DE) 2014-03-06 — — WO disclosed
WO-2014032732-A1 HALOGENATED BENZOXAZINES AND USE THEREOF EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT (DE) 2014-03-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166572-A1 HALOGENATED BENZOXAZINES AND THEIR USE XDH, BAZ1A, CYP4Z1 SLC29A1 2045/4885HTT 62/4885MAPT 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback